BettyKrueger

Atrial Fibrillation Market Analysis and Drugs Statistics 2011-2020

Press Release   •   May 10, 2016 07:17 EDT

The Atrial Fibrillation-Market Insights & Drugs Sales Forecast (AF) -2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. According to DelveInsight, Global Atrial Fibrillation market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%.

Coagulation is an important phenomenon of body to stop external bleeding but when clots are formed in blood vessels, it can be lethal. Blood clots in arteries can lead to heart attack and when formed in the blood vessels of brain can lead to stroke. Thus, anticoagulants are used to prevent the formation of blood clots in the body. Anticoagulants are proved to be a beneficial medication for the treatment of Atrial fibrillation, Deep Vein Thrombosis, Pulmonary Embolism and Stroke.

Complete Report Spread across 70 pages with 20 Figures Now Available. Get SAMPLE of This Report http://www.rnrmarketresearch.com/contacts/request-sample?rname=539789

Key Coverage and Benefits:

  • §The report will help in developing business strategies by understanding the trends shaping and driving the global Atrial Fibrillation (AF) market.
  • §Identifying patient populations in the global Atrial Fibrillation (AF) market to improve product design, pricing, and launch plans.
  • §Organize sales and marketing efforts by identifying the best opportunities for Atrial Fibrillation (AF) therapeutics in each of the markets covered.
  • §To understand the future market competition in the global Atrial Fibrillation (AF) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • §Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management and current treatment options.
  • §Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • §The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2015-2020.
  • §It also provides Atrial fibrillation (AF) for United States, EU5 and Japan from 2015 and forecasted Market to 2020.

Order a Copy of This Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=539789

Table of Contents

Chapter 1 Anticoagulants Introduction

Chapter 2 Atrial Fibrillation

Chapter 3 Key Marketed Anticoagulants

Chapter 4 Anticoagulants Market Assessment by AF

Chapter 5 United States Anticoagulants Market Assessment by AF

Chapter 6 Europe 5 Anticoagulants Market Assessment by AF

Chapter 7 Japan Anticoagulants Market Assessment by AF

Chapter 8 Xarelto (rivaroxaban) Drug Profile

Chapter 9 Pradaxa (dabigatran etexilate mesylate) Drug Profile

Chapter 10 Eliquis(Apixaban) Drug Profile

Chapter 11 Savaysa (edoxaban tosylate) Drug Profile

Chapter 12 Market Drivers and Constraints

About Us:
Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us:
We provide 24/7 online and offline support to our customers. Contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
sales@rnrmarketresearch.com
+ 1 888 391 5441